type 2 diabetes mellitus. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group:
10 g/day of Purslane seed powder with 240cc low fat yogurt for 5 weeks. Intervention 2: Control group
240cc/day low fat yogurt for 5 weeks.
Intervention group:
10 g/day of Purslane seed powder with 240cc low fat yogurt for 5 weeks
Control group
240cc/day low fat yogurt for 5 weeks
Sponsors
Vice-chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Non- Insulin dependent type 2 diabetic Patients; Not smoking and alcohol; Not consume supplement two weeks before the study and during the study; Not pregnant and lactation; Age 35-65 years; Not Change in dose and type of drug at least two month prior to entry study; No history of hepatic, renal, lung, cardiovascular, kidney stone, thyroid diseases and gastro-intestinal bleeding; No history of myocardial infarction and stroke; Not affected by Severe non-proliferative or proliferative retinopathy; Not affected by malignant hypertension exclusion criteria: Change in diet or physical activity patterns for any reason; Receiving Insulin during study; Changes in dosage and type of medications throughout the study; Unwillingness to continue
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: enzymatic method.;Serum Insulin. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: IRMA.;HOMA-IR. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: formula.;Triglyceride. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: enzymatic method.;Total cholesterol. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: enzymatic method.;LDL. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: Friedewald formula.;HDL. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: enzymatic method.;Apo lipoprotein A. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: immunoturbidimetry.;Apo lipoprotein B. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: immunoturbidimetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: scale.;Waist circumference. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: meter.;Systolic blood pressure. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: sphygmomanometer.;Diastolic blood pressure. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: sphygmomanometer.;BMI. Timepoint: In the beginning and at the end of each intervention phase. Method of measurement: formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElahe zakizadeh
School of Public Health, Tehran University
Outcome results
None listed